started · updated
Hone Health secures $228 million to expand longevity platform
Hone Health, a direct-to-consumer longevity platform, has raised $228 million in financing to expand its physician-led care, AI technology, and diagnostic offerings. The funding includes $28 million in Series A equity and $200 million in growth financing from General Catalyst’s Customer Value Fund.
Led by MarcyPen Capital Partners, the investment round included participation from Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital, and ID Ventures. Kinship Ventures was co-founded by Gwyneth Paltrow, who expressed support for the company’s mission to bring science-based wellness to a broader audience.
Founded in 2020 by CEO Saad Alam, Hone Health has treated over 200,000 patients and administered more than 750,000 tests. While initially focused on hormone optimization, the company has expanded into weight management, cardiovascular health, and menopause treatment.
The new capital will support expansion into metabolic health, inflammation, and immunity. The company also plans to integrate advanced diagnostic tools, such as MRIs, DEXA scans, and coronary CT angiography, into its care models. Additionally, Hone Health will invest in its proprietary AI platform, Longevity OS, to assist physicians in developing personalized care plans.
Entities
General Catalyst · Gwyneth Paltrow · Hone Health · MarcyPen Capital Partners · Saad Alam